National Investment Services Inc. WI decreased its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 6.6% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 14,404 shares of the medical research company’s stock after selling 1,016 shares during the quarter. Thermo Fisher Scientific comprises approximately 2.6% of National Investment Services Inc. WI’s investment portfolio, making the stock its 9th largest position. National Investment Services Inc. WI’s holdings in Thermo Fisher Scientific were worth $2,735,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently added to or reduced their stakes in TMO. Univest Corp of Pennsylvania grew its position in Thermo Fisher Scientific by 3.1% in the 2nd quarter. Univest Corp of Pennsylvania now owns 21,029 shares of the medical research company’s stock valued at $3,669,000 after purchasing an additional 631 shares during the period. Papp L Roy & Associates grew its position in Thermo Fisher Scientific by 11.3% in the 2nd quarter. Papp L Roy & Associates now owns 58,650 shares of the medical research company’s stock valued at $10,233,000 after purchasing an additional 5,933 shares during the period. Parsec Financial Management Inc. grew its position in Thermo Fisher Scientific by 8.4% in the 2nd quarter. Parsec Financial Management Inc. now owns 2,093 shares of the medical research company’s stock valued at $365,000 after purchasing an additional 163 shares during the period. Welch & Forbes LLC grew its position in Thermo Fisher Scientific by 0.3% in the 2nd quarter. Welch & Forbes LLC now owns 12,148 shares of the medical research company’s stock valued at $2,120,000 after purchasing an additional 34 shares during the period. Finally, Korea Investment CORP grew its position in Thermo Fisher Scientific by 6.8% in the 2nd quarter. Korea Investment CORP now owns 483,639 shares of the medical research company’s stock valued at $84,380,000 after purchasing an additional 30,744 shares during the period. Hedge funds and other institutional investors own 86.25% of the company’s stock.
Several analysts recently issued reports on the stock. Zacks Investment Research downgraded shares of Thermo Fisher Scientific from a “hold” rating to a “sell” rating in a research report on Thursday, January 11th. Deutsche Bank set a $226.00 price target on shares of Thermo Fisher Scientific and gave the company a “buy” rating in a research report on Thursday, October 26th. BTIG Research assumed coverage on shares of Thermo Fisher Scientific in a research report on Friday, January 5th. They issued a “buy” rating and a $230.00 price target for the company. Leerink Swann lifted their price target on shares of Thermo Fisher Scientific from $190.00 to $207.00 and gave the company an “outperform” rating in a research report on Monday, October 9th. Finally, Evercore ISI assumed coverage on shares of Thermo Fisher Scientific in a report on Wednesday, January 3rd. They set an “outperform” rating and a $220.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and fifteen have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $212.21.
In other news, CEO Marc N. Casper sold 50,000 shares of Thermo Fisher Scientific stock in a transaction on Friday, December 15th. The stock was sold at an average price of $191.74, for a total transaction of $9,587,000.00. Following the sale, the chief executive officer now directly owns 302,577 shares in the company, valued at approximately $58,016,113.98. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.49% of the company’s stock.
Thermo Fisher Scientific Inc. (NYSE TMO) traded up $3.47 on Thursday, reaching $211.48. 1,461,900 shares of the company’s stock were exchanged, compared to its average volume of 1,600,827. The company has a quick ratio of 0.81, a current ratio of 1.26 and a debt-to-equity ratio of 0.85. The stock has a market cap of $84,190.00, a P/E ratio of 35.90, a price-to-earnings-growth ratio of 1.69 and a beta of 1.06. Thermo Fisher Scientific Inc. has a 1 year low of $140.00 and a 1 year high of $211.81.
Thermo Fisher Scientific (NYSE:TMO) last posted its quarterly earnings data on Wednesday, October 25th. The medical research company reported $2.31 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.24 by $0.07. The firm had revenue of $5.12 billion for the quarter, compared to the consensus estimate of $5.03 billion. Thermo Fisher Scientific had a net margin of 11.73% and a return on equity of 15.94%. The business’s revenue for the quarter was up 13.9% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.03 EPS. sell-side analysts forecast that Thermo Fisher Scientific Inc. will post 9.36 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which was paid on Monday, January 15th. Stockholders of record on Friday, December 15th were paid a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.28%. The ex-dividend date of this dividend was Thursday, December 14th. Thermo Fisher Scientific’s payout ratio is 10.19%.
COPYRIGHT VIOLATION WARNING: “Thermo Fisher Scientific Inc. (TMO) Shares Sold by National Investment Services Inc. WI” was originally reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this piece on another website, it was stolen and republished in violation of US & international trademark & copyright laws. The correct version of this piece can be accessed at https://ledgergazette.com/2018/01/18/thermo-fisher-scientific-inc-tmo-holdings-cut-by-national-investment-services-inc-wi.html.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.